Overview
Tekton Research delivered exceptional results in a recent Type 1 Diabetes clinical trial by leveraging its multi-site endocrinology expertise, operational efficiency, and proven site management processes. All three Tekton sites exceeded enrollment targets, contributing to the study’s success.
Key Metrics
Goal: 18 | Enrolled: >30
Notably, our McKinney, TX site achieved this milestone in just 4 business days, demonstrating our ability to mobilize quickly and efficiently
Solutions
Tekton’s centralized services team leverages a streamlined, proven approach to ensure sites are up and running quickly. With a single point of contact for all site communications, centralized regulatory and IRB coordination, and unified budgeting and contracting processes, sponsors benefit from a fast, predictable, and efficient start-up. Real-time operational dashboards and accurate centralized invoicing keep everything on track and transparent from day one.
Beyond the robust practice databases at our embedded endocrinology research sites, Tekton's dedicated Patient Recruitment Center in Austin, TX maintains a robust database of trial-ready individuals and stays in touch through regular outreach via email, phone calls, and text messages. By pre-identifying potential participants year-round and engaging with diverse communities through local events and initiatives, we ensure rapid enrollment and strong retention when it’s time to launch.
Conclusion
This study reflects Tekton’s ability to deliver above-target enrollment, manage accelerated study startup, and operate across multiple specialized sites with consistency and speed. Our strong relationships with PIs and site staff, combined with disciplined processes, make us a trusted partner for high-performance endocrinology research.
Tekton Sites
- Irving, TX
- McKinney, TX
- San Antonio, TX
